Skip to main content

Advertisement

SpringerLink
Log in

Usefulness of Surgical Apgar Score on Predicting Survival After Surgery for Gastric Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Complete surgical resection is essential for a cure for most gastric cancer. Recently it was reported that surgical Apgar score (SAS) can predict postoperative complication and that postoperative complication is associated with poor long-term survival. The aim of this study is to assess whether SAS can predict overall survival (OS) after surgery for gastric cancer.

Methods

We retrospectively compared clinicopathological characteristics and survival between high and low SAS score groups in patients who underwent gastrectomy for gastric cancer.

Results

Low-scored SAS group (group L) was significantly more common among ASA-PS 2, open approach, total gastrectomy, D2 lymph node dissection, postoperative complication grade 2–4, deep tumor invasion, lymph node metastases, and advanced pathological TNM stage than high-scored SAS group (group H). The 5-year OS of group H and group L were 81.6 and 55.9 %, respectively (p < .001); OS of group L tended to be poorer than that of group H in stage III patients (p = .060) and in stage IV patients (p < .001). In multivariate analysis, pathological stage and SAS were identified as independent predictors for OS.

Conclusions

SAS is useful for predicting survival after surgery for gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr, accessed March 25, 2016.

  2. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1990;340:908–14.

    Article  Google Scholar 

  3. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347:995–9.

    CAS  PubMed  Google Scholar 

  4. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.

    Article  CAS  PubMed  Google Scholar 

  5. Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized trial (KLASS Trial). Ann Surg. 2010;51:417–20.

    Article  Google Scholar 

  6. Katai H, Sasako M, Fukuda H, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer. 2010;13:238–44.

    Article  PubMed  Google Scholar 

  7. Gawande AA, Kwaan MR, Regenbogen SE, Lipsitz SA, Zinner MJ. An Apgar score for surgery. J Am Coll Surg. 2007;204:201–8.

    Article  PubMed  Google Scholar 

  8. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315–21.

    Article  CAS  PubMed  Google Scholar 

  9. Regenbogen SE, Lancaster RT, Lipsitz SR, Greenberg CC, Hutter MM, Gawande AA. Does the Surgical Apgar Score measure intraoperative performance? Ann Surg. 2008; 248:320–328.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Prasad SM, Ferreria M, Berry AM, Lipsitz SR, Richie JP, Gawande AA, Hu JC. Surgical Apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol. 2009;181:1046–52.

    Article  PubMed  Google Scholar 

  11. Haynes AB, Regenbogen SE, Weiser TG, et al. Surgical outcome measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries. Surgery. 2011;149:519–24.

    Article  PubMed  Google Scholar 

  12. Regenbogen SE, Ehrenfeld JM, Lipsitz SR, Greenberg CC, Hutter MM, Gawande AA. Utility of the surgical apgar score: validation in 4119 patients. Arch Surg. 2009;144:30–6.

    Article  PubMed  Google Scholar 

  13. Zighelboim I, Kizer N, Taylor NP, et al. “Surgical Apgar Score” predicts postoperative complications after cytoreduction for advanced ovarian cancer. Gynecol Oncol. 2010;116:370–3.

    Article  PubMed  Google Scholar 

  14. Regenbogen SE, Bordeianou L, Hutter MM, Gawande AA. The intraoperative Surgical Apgar Score predicts postdischarge complications after colon and rectal resection. Surgery. 2010;148:559–66.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Yamada T, Tsuburaya A, Hayashi T, et al. Surgical Apgar score predicts postoperative complications after surgery for gastric cancer. Glob Surg. 2015;1:48–51.

    Article  Google Scholar 

  16. Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2014;20:1575–83.

    Article  Google Scholar 

  17. Hayashi T, Yoshikawa T, Aoyama T, et al. Impact of infectious complications on gastric cancer recurrence. Gastric Cancer. 2015;18:368–74.

    Article  PubMed  Google Scholar 

  18. Li QG, Li P, Tang D, Chen J, Wang DR. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J Gastroenterol. 2013;19:4060–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sobin LH, Gospodarowicz MK, Witterkind CH. International Union Against Cancer (UICC) TNM Classification of Malignant Tumors. 7th ed. Oxford, UK: Wiley-Blackwell. 2009.

    Google Scholar 

  20. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.

    Article  Google Scholar 

  21. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17:309–18.

    Article  CAS  PubMed  Google Scholar 

  23. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100:4–10.

    Article  PubMed  Google Scholar 

  24. Kawasaki T, Ogata M, Kawasaki C, Okamoto K, Sata T. Effects of epidural anaesthesia on surgical stress-induced immunosuppression during upper abdominal surgery. Br J Anaesth. 2007;98:196–203.

    Article  CAS  PubMed  Google Scholar 

  25. Zhao J, Mo H. The impact of different anesthesia methods on stress reaction and immune function of the patients with gastric cancer during peri-operative period. J Med Assoc Thai. 2015;98:568–73.

    PubMed  Google Scholar 

Download references

Acknowledgment

None.

Disclosure

None.

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

    Takanobu Yamada MD, Tsutomu Hayashi MD, Toru Aoyama MD, PhD, Hirohito Fujikawa MD, Junya Shirai MD, Haruhiko Cho MD, PhD & Takaki Yoshikawa MD, PhD

  2. Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan

    Takanobu Yamada MD, Akira Tsuburaya MD, PhD, Yasushi Rino MD, PhD, Munetaka Masuda MD, PhD & Takaki Yoshikawa MD, PhD

  3. Department of Anesthesiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

    Toshio Sasaki MD, PhD

Authors
  1. Takanobu Yamada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Tsuburaya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsutomu Hayashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toru Aoyama MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirohito Fujikawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junya Shirai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haruhiko Cho MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Toshio Sasaki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yasushi Rino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Munetaka Masuda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takaki Yoshikawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takanobu Yamada MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, T., Tsuburaya, A., Hayashi, T. et al. Usefulness of Surgical Apgar Score on Predicting Survival After Surgery for Gastric Cancer. Ann Surg Oncol 23 (Suppl 5), 757–763 (2016). https://doi.org/10.1245/s10434-016-5525-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5525-4

Keywords

Search

Navigation